Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial

Thoracic surgery is a high-risk surgery especially for the risk of postoperative pulmonary complications. Postoperative residual paralysis has been shown to be a risk factor for pulmonary complications. Nevertheless, there are few data in the literature concerning the use of neuromuscular blocking a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Anesthesia, Analgesia and Critical Care (Online) Analgesia and Critical Care (Online), 2024-02, Vol.4 (1), p.9-9, Article 9
Main Authors: Piccioni, Federico, Rosboch, Giulio L, Coccia, Cecilia, Donati, Ilaria, Proto, Paolo, Ceraolo, Edoardo, Pierconti, Federico, Pagano, Martina, Vernocchi, Daniele, Valenza, Franco, Rocca, Giorgio Della
Format: Article
Language:English
Subjects:
Anesthesia
Chronic obstructive pulmonary disease
Drug dosages
Enrollments
Extubation
Medical personnel
Neostigmine
Neuromuscular blockade
Patients
Postoperative complications
Software
Sugammadex
Surgical outcomes
Thoracic surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c392t-ed08fc5f4abd830c7bc759b2518464e772fef9d16d702afbe739d200a9ab9f3
container_end_page 9
container_issue 1
container_start_page 9
container_title Journal of Anesthesia, Analgesia and Critical Care (Online)
container_volume 4
creator Piccioni, Federico
Rosboch, Giulio L
Coccia, Cecilia
Donati, Ilaria
Proto, Paolo
Ceraolo, Edoardo
Pierconti, Federico
Pagano, Martina
Vernocchi, Daniele
Valenza, Franco
Rocca, Giorgio Della
description Thoracic surgery is a high-risk surgery especially for the risk of postoperative pulmonary complications. Postoperative residual paralysis has been shown to be a risk factor for pulmonary complications. Nevertheless, there are few data in the literature concerning the use of neuromuscular blocking agent antagonists in patients undergoing lung surgery. Seventy patients were randomized in three Italian centers to receive sugammadex or neostigmine at the end of thoracic surgery according to the depth of the residual neuromuscular block. The primary outcome was the time from reversal administration to a train-of-four ratio (TOFR) of 0.9. Secondary outcomes were the time to TOFR of 1.0, to extubation, to postanesthesia unit (PACU) discharge, postoperative complications until 30 days after surgery, and length of hospital stay. Median time to recovery to a TOFR of 0.9 was significantly shorter in the sugammadex group compared to the neostigmine one (88 vs. 278 s - P 
doi_str_mv 10.1186/s44158-024-00146-6
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cc22562476564fdeb815d9b2b157b760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cc22562476564fdeb815d9b2b157b760</doaj_id><sourcerecordid>2923629249</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-ed08fc5f4abd830c7bc759b2518464e772fef9d16d702afbe739d200a9ab9f3</originalsourceid><addsrcrecordid>eNpdksluFDEURUsIRKKQH2CBLLEJiwJPZZfZtRKGSJFY0HvLY8ctl93YVRLkS_hcXN0hQqw86L7znq9v171G8D1CI_tQKUXD2ENMewgRZT171p1jTlBP-Mie_7M_6y5r3UMI8ThwItDL7oyMhCDBxHn3-8aZpagSHtQccgIbP7sCtve5KBMM2CRX53tXgwJLDWkH6rJT06Ss-wlMng6qOAvmDJLLdQ67KSQHrm422w2YS1Dx3UegwLTEORiXVnBRyeYpPLQqmxcdXa9jSLYdTU5zyTGuvLX0VffCq1jd5eN60X3__Gl7_bW_-_bl9npz1xsi8Nw7C0dvBk-VtiOBhmvDB6HxgEbKqOMce-eFRcxyiJXXrjlgMYRKKC08uehuT1Sb1V4eSphU-SWzCvJ4kctOqtKmj04ag_HAMOVsYNRbp0c02NZJo4FrzmBjXZ1Yh5J_LM03OYVqXIyqubNUiQWmQrARsyZ9-590n5eS2jtXFWFHaVPhk8qUXGtx_mlABOUaAnkKgWwhkMcQyBX95hG96MnZp5K_X07-ALwsrt8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2923629249</pqid></control><display><type>article</type><title>Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial</title><source>PubMed (Medline)</source><source>Publicly Available Content (ProQuest)</source><creator>Piccioni, Federico ; Rosboch, Giulio L ; Coccia, Cecilia ; Donati, Ilaria ; Proto, Paolo ; Ceraolo, Edoardo ; Pierconti, Federico ; Pagano, Martina ; Vernocchi, Daniele ; Valenza, Franco ; Rocca, Giorgio Della</creator><creatorcontrib>Piccioni, Federico ; Rosboch, Giulio L ; Coccia, Cecilia ; Donati, Ilaria ; Proto, Paolo ; Ceraolo, Edoardo ; Pierconti, Federico ; Pagano, Martina ; Vernocchi, Daniele ; Valenza, Franco ; Rocca, Giorgio Della</creatorcontrib><description>Thoracic surgery is a high-risk surgery especially for the risk of postoperative pulmonary complications. Postoperative residual paralysis has been shown to be a risk factor for pulmonary complications. Nevertheless, there are few data in the literature concerning the use of neuromuscular blocking agent antagonists in patients undergoing lung surgery. Seventy patients were randomized in three Italian centers to receive sugammadex or neostigmine at the end of thoracic surgery according to the depth of the residual neuromuscular block. The primary outcome was the time from reversal administration to a train-of-four ratio (TOFR) of 0.9. Secondary outcomes were the time to TOFR of 1.0, to extubation, to postanesthesia unit (PACU) discharge, postoperative complications until 30 days after surgery, and length of hospital stay. Median time to recovery to a TOFR of 0.9 was significantly shorter in the sugammadex group compared to the neostigmine one (88 vs. 278 s - P &lt; 0.001). The percentage of patients who recovered to a TOFR of 0.9 within 5 min from reversal administration was 94.4% and 58.8% in the sugammadex and neostigmine groups, respectively (P &lt; 0.001). The time to extubation, but not the PACU stay time, was significantly shorter in the sugammadex group. No differences were found between the study groups as regards postoperative complications and length of hospital stay. The superiority of sugammadex in shortening the recovery time was confirmed for both deep/moderate and shallow/minimal neuromuscular block. Among patients undergoing thoracic surgery, sugammadex ensures a faster recovery from the neuromuscular block and earlier extubation compared to neostigmine.</description><identifier>ISSN: 2731-3786</identifier><identifier>EISSN: 2731-3786</identifier><identifier>DOI: 10.1186/s44158-024-00146-6</identifier><identifier>PMID: 38331969</identifier><language>eng</language><publisher>England: Springer Nature B.V</publisher><subject>Anesthesia ; Chronic obstructive pulmonary disease ; Drug dosages ; Enrollments ; Extubation ; Medical personnel ; Neostigmine ; Neuromuscular blockade ; Patients ; Postoperative complications ; Software ; Sugammadex ; Surgical outcomes ; Thoracic surgery</subject><ispartof>Journal of Anesthesia, Analgesia and Critical Care (Online), 2024-02, Vol.4 (1), p.9-9, Article 9</ispartof><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c392t-ed08fc5f4abd830c7bc759b2518464e772fef9d16d702afbe739d200a9ab9f3</cites><orcidid>0000-0002-9589-1891</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2923629249/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2923629249?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,25734,27905,27906,36993,36994,44571,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38331969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piccioni, Federico</creatorcontrib><creatorcontrib>Rosboch, Giulio L</creatorcontrib><creatorcontrib>Coccia, Cecilia</creatorcontrib><creatorcontrib>Donati, Ilaria</creatorcontrib><creatorcontrib>Proto, Paolo</creatorcontrib><creatorcontrib>Ceraolo, Edoardo</creatorcontrib><creatorcontrib>Pierconti, Federico</creatorcontrib><creatorcontrib>Pagano, Martina</creatorcontrib><creatorcontrib>Vernocchi, Daniele</creatorcontrib><creatorcontrib>Valenza, Franco</creatorcontrib><creatorcontrib>Rocca, Giorgio Della</creatorcontrib><title>Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial</title><title>Journal of Anesthesia, Analgesia and Critical Care (Online)</title><addtitle>J Anesth Analg Crit Care</addtitle><description>Thoracic surgery is a high-risk surgery especially for the risk of postoperative pulmonary complications. Postoperative residual paralysis has been shown to be a risk factor for pulmonary complications. Nevertheless, there are few data in the literature concerning the use of neuromuscular blocking agent antagonists in patients undergoing lung surgery. Seventy patients were randomized in three Italian centers to receive sugammadex or neostigmine at the end of thoracic surgery according to the depth of the residual neuromuscular block. The primary outcome was the time from reversal administration to a train-of-four ratio (TOFR) of 0.9. Secondary outcomes were the time to TOFR of 1.0, to extubation, to postanesthesia unit (PACU) discharge, postoperative complications until 30 days after surgery, and length of hospital stay. Median time to recovery to a TOFR of 0.9 was significantly shorter in the sugammadex group compared to the neostigmine one (88 vs. 278 s - P &lt; 0.001). The percentage of patients who recovered to a TOFR of 0.9 within 5 min from reversal administration was 94.4% and 58.8% in the sugammadex and neostigmine groups, respectively (P &lt; 0.001). The time to extubation, but not the PACU stay time, was significantly shorter in the sugammadex group. No differences were found between the study groups as regards postoperative complications and length of hospital stay. The superiority of sugammadex in shortening the recovery time was confirmed for both deep/moderate and shallow/minimal neuromuscular block. Among patients undergoing thoracic surgery, sugammadex ensures a faster recovery from the neuromuscular block and earlier extubation compared to neostigmine.</description><subject>Anesthesia</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Drug dosages</subject><subject>Enrollments</subject><subject>Extubation</subject><subject>Medical personnel</subject><subject>Neostigmine</subject><subject>Neuromuscular blockade</subject><subject>Patients</subject><subject>Postoperative complications</subject><subject>Software</subject><subject>Sugammadex</subject><subject>Surgical outcomes</subject><subject>Thoracic surgery</subject><issn>2731-3786</issn><issn>2731-3786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdksluFDEURUsIRKKQH2CBLLEJiwJPZZfZtRKGSJFY0HvLY8ctl93YVRLkS_hcXN0hQqw86L7znq9v171G8D1CI_tQKUXD2ENMewgRZT171p1jTlBP-Mie_7M_6y5r3UMI8ThwItDL7oyMhCDBxHn3-8aZpagSHtQccgIbP7sCtve5KBMM2CRX53tXgwJLDWkH6rJT06Ss-wlMng6qOAvmDJLLdQ67KSQHrm422w2YS1Dx3UegwLTEORiXVnBRyeYpPLQqmxcdXa9jSLYdTU5zyTGuvLX0VffCq1jd5eN60X3__Gl7_bW_-_bl9npz1xsi8Nw7C0dvBk-VtiOBhmvDB6HxgEbKqOMce-eFRcxyiJXXrjlgMYRKKC08uehuT1Sb1V4eSphU-SWzCvJ4kctOqtKmj04ag_HAMOVsYNRbp0c02NZJo4FrzmBjXZ1Yh5J_LM03OYVqXIyqubNUiQWmQrARsyZ9-590n5eS2jtXFWFHaVPhk8qUXGtx_mlABOUaAnkKgWwhkMcQyBX95hG96MnZp5K_X07-ALwsrt8</recordid><startdate>20240208</startdate><enddate>20240208</enddate><creator>Piccioni, Federico</creator><creator>Rosboch, Giulio L</creator><creator>Coccia, Cecilia</creator><creator>Donati, Ilaria</creator><creator>Proto, Paolo</creator><creator>Ceraolo, Edoardo</creator><creator>Pierconti, Federico</creator><creator>Pagano, Martina</creator><creator>Vernocchi, Daniele</creator><creator>Valenza, Franco</creator><creator>Rocca, Giorgio Della</creator><general>Springer Nature B.V</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9589-1891</orcidid></search><sort><creationdate>20240208</creationdate><title>Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial</title><author>Piccioni, Federico ; Rosboch, Giulio L ; Coccia, Cecilia ; Donati, Ilaria ; Proto, Paolo ; Ceraolo, Edoardo ; Pierconti, Federico ; Pagano, Martina ; Vernocchi, Daniele ; Valenza, Franco ; Rocca, Giorgio Della</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-ed08fc5f4abd830c7bc759b2518464e772fef9d16d702afbe739d200a9ab9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anesthesia</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Drug dosages</topic><topic>Enrollments</topic><topic>Extubation</topic><topic>Medical personnel</topic><topic>Neostigmine</topic><topic>Neuromuscular blockade</topic><topic>Patients</topic><topic>Postoperative complications</topic><topic>Software</topic><topic>Sugammadex</topic><topic>Surgical outcomes</topic><topic>Thoracic surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piccioni, Federico</creatorcontrib><creatorcontrib>Rosboch, Giulio L</creatorcontrib><creatorcontrib>Coccia, Cecilia</creatorcontrib><creatorcontrib>Donati, Ilaria</creatorcontrib><creatorcontrib>Proto, Paolo</creatorcontrib><creatorcontrib>Ceraolo, Edoardo</creatorcontrib><creatorcontrib>Pierconti, Federico</creatorcontrib><creatorcontrib>Pagano, Martina</creatorcontrib><creatorcontrib>Vernocchi, Daniele</creatorcontrib><creatorcontrib>Valenza, Franco</creatorcontrib><creatorcontrib>Rocca, Giorgio Della</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Anesthesia, Analgesia and Critical Care (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piccioni, Federico</au><au>Rosboch, Giulio L</au><au>Coccia, Cecilia</au><au>Donati, Ilaria</au><au>Proto, Paolo</au><au>Ceraolo, Edoardo</au><au>Pierconti, Federico</au><au>Pagano, Martina</au><au>Vernocchi, Daniele</au><au>Valenza, Franco</au><au>Rocca, Giorgio Della</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial</atitle><jtitle>Journal of Anesthesia, Analgesia and Critical Care (Online)</jtitle><addtitle>J Anesth Analg Crit Care</addtitle><date>2024-02-08</date><risdate>2024</risdate><volume>4</volume><issue>1</issue><spage>9</spage><epage>9</epage><pages>9-9</pages><artnum>9</artnum><issn>2731-3786</issn><eissn>2731-3786</eissn><abstract>Thoracic surgery is a high-risk surgery especially for the risk of postoperative pulmonary complications. Postoperative residual paralysis has been shown to be a risk factor for pulmonary complications. Nevertheless, there are few data in the literature concerning the use of neuromuscular blocking agent antagonists in patients undergoing lung surgery. Seventy patients were randomized in three Italian centers to receive sugammadex or neostigmine at the end of thoracic surgery according to the depth of the residual neuromuscular block. The primary outcome was the time from reversal administration to a train-of-four ratio (TOFR) of 0.9. Secondary outcomes were the time to TOFR of 1.0, to extubation, to postanesthesia unit (PACU) discharge, postoperative complications until 30 days after surgery, and length of hospital stay. Median time to recovery to a TOFR of 0.9 was significantly shorter in the sugammadex group compared to the neostigmine one (88 vs. 278 s - P &lt; 0.001). The percentage of patients who recovered to a TOFR of 0.9 within 5 min from reversal administration was 94.4% and 58.8% in the sugammadex and neostigmine groups, respectively (P &lt; 0.001). The time to extubation, but not the PACU stay time, was significantly shorter in the sugammadex group. No differences were found between the study groups as regards postoperative complications and length of hospital stay. The superiority of sugammadex in shortening the recovery time was confirmed for both deep/moderate and shallow/minimal neuromuscular block. Among patients undergoing thoracic surgery, sugammadex ensures a faster recovery from the neuromuscular block and earlier extubation compared to neostigmine.</abstract><cop>England</cop><pub>Springer Nature B.V</pub><pmid>38331969</pmid><doi>10.1186/s44158-024-00146-6</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-9589-1891</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2731-3786
ispartof Journal of Anesthesia, Analgesia and Critical Care (Online), 2024-02, Vol.4 (1), p.9-9, Article 9
issn 2731-3786
2731-3786
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_cc22562476564fdeb815d9b2b157b760
source PubMed (Medline); Publicly Available Content (ProQuest)
subjects Anesthesia
Chronic obstructive pulmonary disease
Drug dosages
Enrollments
Extubation
Medical personnel
Neostigmine
Neuromuscular blockade
Patients
Postoperative complications
Software
Sugammadex
Surgical outcomes
Thoracic surgery
title Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A35%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decurarization%20After%20Thoracic%20Anesthesia%20using%20sugammadex%20compared%20to%20neostigmine%20(DATA%20trial):%20a%20multicenter%20randomized%20double-blinded%20controlled%20trial&rft.jtitle=Journal%20of%20Anesthesia,%20Analgesia%20and%20Critical%20Care%20(Online)&rft.au=Piccioni,%20Federico&rft.date=2024-02-08&rft.volume=4&rft.issue=1&rft.spage=9&rft.epage=9&rft.pages=9-9&rft.artnum=9&rft.issn=2731-3786&rft.eissn=2731-3786&rft_id=info:doi/10.1186/s44158-024-00146-6&rft_dat=%3Cproquest_doaj_%3E2923629249%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-ed08fc5f4abd830c7bc759b2518464e772fef9d16d702afbe739d200a9ab9f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2923629249&rft_id=info:pmid/38331969&rfr_iscdi=true